KOLs Discuss Potential of Non-GLP1 Mechanism for Metabolic Rewiring
ObesityWeek November 2024 Satellite Event Presentation
New insights from KOLs and management regarding centrally vs peripherally-driven CB1 inhibition, and data from Skye’s diet-induced obesity model highlighting dose-dependent weight loss.
